Alnylam Ready To Expand TTR Franchise With Positive Cardiomyopathy Results

Supplemental Onpattro US Filing Planned For Late 2022

 
• By Mandy Jackson
RNA, Epigenetics concept, 3d illustration
Onpattro silences the RNA that makes the TTR protein • Source: Shutterstock

More from Clinical Trials

More from R&D